Zobrazeno 1 - 5
of 5
pro vyhledávání: '"W J, Rusho"'
Autor:
H D, Owsley, W J, Rusho
Publikováno v:
International journal of pharmaceutical compounding. 1(2)
Respiratory therapists are being asked to take care of sicker patients and in many cases this requires the administration of multiple inhalation drugs. In an effort to reduce the workload, therapists are combining drugs in the same nebulizer. Pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec1b9c9a2f9c3f11e0345d239aa3519f
https://pubmed.ncbi.nlm.nih.gov/23995969
https://pubmed.ncbi.nlm.nih.gov/23995969
Publikováno v:
American journal of hospital pharmacy. 50(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d3da0a778e518331e58f8be8e01e5e9
https://pubmed.ncbi.nlm.nih.gov/8368214
https://pubmed.ncbi.nlm.nih.gov/8368214
Publikováno v:
American journal of hospital pharmacy. 39(1)
Factors affecting calcium-phosphate solubility in parenteral nutrition solutions used in neonates were studied. Six neonatal parenteral nutrition solutions were prepared using either Aminosyn or FreAmine III and various amino acid and dextrose concen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e61f91962d3c6d46d137b3c465179718
https://pubmed.ncbi.nlm.nih.gov/6798868
https://pubmed.ncbi.nlm.nih.gov/6798868
Autor:
W J, Rusho, J N, Bair
Publikováno v:
American journal of hospital pharmacy. 36(10)
The incidence of intravenous complications (phlebitis) and the length of hospital stay in postoperative patients whose infusions were filtered through inline final filters were compared with those in patients whose infusions were not filtered. Identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5a1c60c00c18bff1fafa024ad0dc21b
https://pubmed.ncbi.nlm.nih.gov/507079
https://pubmed.ncbi.nlm.nih.gov/507079
Autor:
C R, Smart, L B, Townsend, W J, Rusho, H J, Eyre, J M, Quagliana, M L, Wilson, C B, Edwards, S J, Manning
Publikováno v:
Cancer. 36(1)
Ftorafur, a furanyl analog of 5-fluorouracil (5-FU), is reported to be five to six times less toxic and possibly more effective in cancer of the breast and colon than 5-FU. The drug was synthesized, formulated, and utilized in toxicologic studies, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95216b2e9c72829e279844d398a4d761
https://pubmed.ncbi.nlm.nih.gov/1203838
https://pubmed.ncbi.nlm.nih.gov/1203838